Suppr超能文献

基于人群的扩大携带者筛查成功实施的因素:借鉴现有举措

Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.

作者信息

Holtkamp Kim C A, Mathijssen Inge B, Lakeman Phillis, van Maarle Merel C, Dondorp Wybo J, Henneman Lidewij, Cornel Martina C

机构信息

Department of Clinical Genetics, Section of Community Genetics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.

Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Eur J Public Health. 2017 Apr 1;27(2):372-377. doi: 10.1093/eurpub/ckw110.

Abstract

BACKGROUND

Carrier screening for autosomal recessive disorders aims to facilitate reproductive decision-making by identifying couples with a 1-in-4 risk in every pregnancy of having an affected child. Except for a few countries or regions, carrier screening is not widely offered and is mostly ancestry-based. Technological advances enable carrier screening for multiple diseases simultaneously allowing universal screening regardless of ancestry (population-based expanded carrier screening). It is important to study how this can be successfully implemented. This study therefore aims to identify critical factors involved in successful implementation, from a user perspective, by learning from already implemented initiatives.

METHODS

Factors associated with successful implementation were identified by: (i) a literature review and (ii) two case studies; studying experiences with carrier screening in two high-risk communities (a Dutch founder population and the Ashkenazi Jewish population), including a survey among community members.

RESULTS

Factors identified were familiarity with (specific) genetic diseases and its availability, high perceived benefits of screening (e.g. screening avoids much suffering), acceptance of reproductive options, perceived risk of being a carrier and low perceived social barriers (e.g. stigmatization). In contrast to the Jewish community, the initial demand for screening in the Dutch founder population did not entirely come from the community itself. However, the large social cohesion of the community facilitated the implementation process.

CONCLUSION

To ensure successful implementation of population-based expanded carrier screening, efforts should be made to increase knowledge about genetic diseases, create awareness and address personal benefits of screening in a non-directive way.

摘要

背景

常染色体隐性疾病的携带者筛查旨在通过识别每一次怀孕都有四分之一几率生育患病子女的夫妇,来促进生育决策。除少数国家或地区外,携带者筛查并未广泛开展,且大多基于血统。技术进步使得能够同时对多种疾病进行携带者筛查,从而实现不分血统的普遍筛查(基于人群的扩展携带者筛查)。研究如何成功实施这一筛查非常重要。因此,本研究旨在从用户角度出发,通过借鉴已实施的举措,确定成功实施所涉及的关键因素。

方法

通过以下方式确定与成功实施相关的因素:(i)文献综述和(ii)两个案例研究;研究两个高危群体(一个荷兰奠基人群体和阿什肯纳兹犹太人群体)的携带者筛查经验,包括对群体成员的调查。

结果

确定的因素包括对(特定)遗传疾病的熟悉程度及其可及性、对筛查的高预期益处(例如筛查可避免许多痛苦)、对生育选择的接受度、对成为携带者的感知风险以及低感知社会障碍(例如污名化)。与犹太群体不同,荷兰奠基人群体对筛查的最初需求并非完全来自群体自身。然而,该群体强大的社会凝聚力促进了实施过程。

结论

为确保基于人群的扩展携带者筛查成功实施,应努力增加对遗传疾病的了解,提高认识,并以非指导性方式阐述筛查的个人益处。

相似文献

2
Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
Eur J Hum Genet. 2016 Feb;24(2):171-7. doi: 10.1038/ejhg.2015.97. Epub 2015 May 13.
3
Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
J Genet Couns. 2015 Jun;24(3):381-7. doi: 10.1007/s10897-014-9800-x. Epub 2014 Dec 12.
4
Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
JAMA. 2007 Sep 19;298(11):1281-90. doi: 10.1001/jama.298.11.1281.
5
Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.
Eur J Hum Genet. 2018 Feb;26(2):166-175. doi: 10.1038/s41431-017-0056-4. Epub 2018 Jan 10.
6
Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape.
BMC Health Serv Res. 2017 Feb 16;17(1):146. doi: 10.1186/s12913-017-2083-9.
7
Targeted carrier screening for four recessive disorders: high detection rate within a founder population.
Eur J Med Genet. 2015 Mar;58(3):123-8. doi: 10.1016/j.ejmg.2015.01.004. Epub 2015 Jan 30.
8
Responsible implementation of expanded carrier screening.
Eur J Hum Genet. 2016 Jun;24(6):e1-e12. doi: 10.1038/ejhg.2015.271. Epub 2016 Mar 16.
9
DNA-based carrier screening in the Ashkenazi Jewish population.
Expert Rev Mol Diagn. 2004 May;4(3):377-92. doi: 10.1586/14737159.4.3.377.

引用本文的文献

2
Scaling-up and future sustainability of a national reproductive genetic carrier screening program.
NPJ Genom Med. 2023 Jul 31;8(1):18. doi: 10.1038/s41525-023-00357-w.
3
Societal implications of expanded universal carrier screening: a scoping review.
Eur J Hum Genet. 2023 Jan;31(1):55-72. doi: 10.1038/s41431-022-01178-8. Epub 2022 Sep 12.
4
Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders.
PLoS One. 2022 Jun 21;17(6):e0269719. doi: 10.1371/journal.pone.0269719. eCollection 2022.
5
Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population.
Public Health Ethics. 2021 Jun 14;14(2):202-217. doi: 10.1093/phe/phab017. eCollection 2021 Jul.
7
Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes.
Eur J Hum Genet. 2021 May;29(5):851-860. doi: 10.1038/s41431-021-00810-3. Epub 2021 Mar 1.
8
Ethical issues in reproductive genetic carrier screening.
Med J Aust. 2021 Mar;214(4):165-167.e1. doi: 10.5694/mja2.50789. Epub 2020 Sep 27.
10
Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening.
Eur J Hum Genet. 2020 Oct;28(10):1331-1340. doi: 10.1038/s41431-020-0648-2. Epub 2020 Jun 1.

本文引用的文献

1
Responsible implementation of expanded carrier screening.
Eur J Hum Genet. 2016 Jun;24(6):e1-e12. doi: 10.1038/ejhg.2015.271. Epub 2016 Mar 16.
2
"Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening.
J Genet Couns. 2016 Feb;25(1):135-45. doi: 10.1007/s10897-015-9851-7. Epub 2015 Jun 21.
3
Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
Eur J Hum Genet. 2016 Feb;24(2):171-7. doi: 10.1038/ejhg.2015.97. Epub 2015 May 13.
4
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
Eur J Hum Genet. 2015 Nov;23(11):1438-50. doi: 10.1038/ejhg.2015.57. Epub 2015 Mar 18.
6
Targeted carrier screening for four recessive disorders: high detection rate within a founder population.
Eur J Med Genet. 2015 Mar;58(3):123-8. doi: 10.1016/j.ejmg.2015.01.004. Epub 2015 Jan 30.
8
Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
Am J Obstet Gynecol. 2014 Sep;211(3):197-204. doi: 10.1016/j.ajog.2014.02.001. Epub 2014 Feb 5.
10
Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.
Genet Med. 2014 Mar;16(3):207-16. doi: 10.1038/gim.2013.125. Epub 2013 Sep 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验